Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier
WebMD

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine
WebMD

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion
    WebMD

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community
    WebMD

    Community

    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Stroke Health Center

Font Size
A
A
A

Stroke Patients Benefit From Lipitor

Statin Lowered Second Stroke Risk by 16%

Benefits vs. Risks

Chicago neurologist K. Michael Welch, MB, ChB, who led the investigation, tells WebMD that the findings argue in favor of adding high-dose Lipitor to the regimen of drugs routinely recommended for strokestroke patients.

"The risk following a first stroke is very high, with 40% of patients having a second stroke within five years," he says.

Because the study included only Lipitor and is the first statin trial to include only stroke patients, Welch says it is not clear if other statin drugs would work as well to lower the risk of secondary stroke and heart attackheart attack in this population.

David M. Kent, MD, agrees that the study provides compelling evidence that most stroke patients should be placed on a statin.

But he tells WebMD that the SPARCL trial left many questions unanswered about the benefits vs. the risks of such treatment for specific patient groups.

Kent is an assistant professor of medicine specializing in health policy research at the Tufts-New England Medicine Center in Boston.

It is not clear, for example, if patients who have had strokes caused by the rupture of an artery within the brain benefit from the treatment, he says.

About one in five stroke patients has this type of stroke, known as a hemorrhagic stroke. Most patients have ischemic strokes, which are caused by a clot within an artery in the brain.

"I think it is clear that the default position should be to start patients who have had ischemic strokes on a statin, but this is not clear for hemorrhagic stroke patients," Kent says. Kent notes in his editorial that statins have anticlotting effects and that there was an increased risk for patients in the Lipitor group to have a hemorrhagic stroke.

Unanswered questions aside, Kent says the biggest threat for stroke patients is not overtreatment with a statin, but undertreatment. He makes the point in an editorial accompanying the study.

"In one recent study, even among [hospitalized stroke] patients who were eligible for statin therapy … only a third had discharge medications that included statins," he wrote.

1 | 2

Today on WebMD

brain illustration stroke
Know these 5 signs.
brain scans
Test your stroke smarts.
 
woman with migraine
Is there a link?
brain scan
Get the facts.
 
brain scans
Quiz
woman with migraine
Article
 
brain scan
Article
headache
Video
 
senior man stretching pre workout
Article
Floor level view of therapist helping stroke patie
Article
 
concerned woman
Article
Lowering Cholesterol Slideshow
SLIDESHOW